• EN

Scientific Paper Award 2014



Scientific Paper Award 2014: winning and shortlisted articles

Basic biological, neurobiological and behavioural research shortlist

  1. Buchmayer, F., Schicker, K., Steinkellner, T., Geier, P., Stübiger, G., Hamilton, P. J., Jurik, A., Stockner, T., Yang, J. W., Montgomery, T., Holy, M., Hofmaier, T., Kudlacek, O., Matthies, H. J., Ecker, G. F., Bochkov, V., Galli, A., Boehm, S., Sitte, H. H. (2013), ‘Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate’, Proceedings of the National Academy of Sciences of the United States of America, 110, 28, p.11642-11647
  2. Dawson, P., Opacka-Juffry, J., Moffatt, J. D., Daniju, Y., Dutta, N., Ramsey, J., Davidson, C., (2014) ‘The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat’, Progress in Neuro-psychopharmacology and Biological Psychiatry, 48, p.57-63
  3. Doucet, E. L., Bobadilla, A. C., Houades, V., Lanteri, C., Godeheu, G., Lanfumey, L., Sara, S. J., Tassin, J. P., (2013), ‘Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine’, Biological Psychiatry, 74, 2, p.90-98

Population based and epidemiology research shortlist

  1. Groenman, A. P., Oosterlaan, J., Rommelse, N., Franke, B., Roeyers, H., Oades R. D., Sergeant, J. A., Buitelaar, J. K., Faraone, S. V. (2013), ‘Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study’, Addiction, 108, 8, p.1503-1511
  2. Gauffin. K., Vinnerljung, B., Fridell, M., Hesse, M., Hjern, A., (2013), ‘Childhood socio-economic status, school failure and drug abuse: a Swedish national cohort study’, Addiction, 108, 8, p.1441-1449
  3. Griffith-Lendering, M. F., Wigman, J. T., Prince van Leeuwen, A., Huijbregts, S. C., Huizink, A. C., Ormel, J., Verhulst, F. C., van Os, J., Swaab, H., Vollebergh, W. A., (2013) ‘Cannabis use and vulnerability for psychosis in early adolescence--a TRAILS study’, Addiction, 108, 4, p.733-740
  4. Heron, J., Barker, E. D., Joinson, C., Lewis, G., Hickman, M., Munafò, M., Macleod, J., (2013) ‘Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study’, Addiction, 108, 12, p.2129-2138
  5. van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., van Laar, M., (2013) ‘Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study’, Drug and Alcohol Dependence, 133, 2, p.352-359

Demand reduction research shortlist

  1. Schaub, M. P. and Uchtenhagen, A. (2013), ‘Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction’, European Addiction Research, 19, 6, p.314-324
  2. Manning, P., (2013), ‘You Tube, ‘drug videos’ and drugs education’, Drugs: education, prevention and policy, 20, 2, p.120-130
  3. Martin, N. K., Vickerman, P., Grebely, J., Hellard, M., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., Hickman, M., (2013) ‘Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals’, Hepatology, 58, 5, p.1598-1609

Policy, supply and crime shortlist

  1. Rehm, J., Marmet, S., Anderson, P., Gual, A., Kraus, L., Nutt, D. J., Room, R., Samokhvalov, A. V., Scafato, E., Trapencieris, M., Wiers, R. W., Gmel, G. (2013), ‘Defining substance use disorders: do we really need more than heavy use?’, Alcohol and Alcoholism, 48, 6, p.633-640
  2. Hout, M. C. V.; Bingham, T., (2013), ‘'Surfing the Silk Road': A study of users' experiences’, International Journal on Drug Policy, 24, 6, p.524-529. Access the full article here.
  3. Lakhdar, Ben C., Leleu, H., Vaillant, N. G., Wolff, F-C., (2013), ‘Efficiency of purchasing and selling agents in markets with quality uncertainty: The case of illicit drug transactions’, European Journal of Operational Research, 226, p.646–657


About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Monday, 24 November 2014